· 方法论
涉及标的： $AAOI$SIVE$IQE$MTSI$IREN$SLNH$BKKT
并不是所有稀释都是坏事，关键取决于融资结构。 如果你通过6亿美元 ATM 融资来建设激光器晶圆厂产能，并且对应 $AAOI 在2027年上半年每月4.71亿美元收入机会（同时市值区间更低），那就是增厚性的。 如果你为了满足纳斯达克上市要求而让 $SIVE 稀释15%，并把募集资金用于并购，那也是增厚性的。 如果你让 $IQE 稀释，并让 $MTSI 做私募来清掉旧的有毒债务，那也是增厚性的。 但如果你像 $IREN 那样稀释60亿美元，并且很可能在每一次反弹时向公开市场抛售，而这些反弹背后是 $SLNH / $BKKT 吹票者推动、其中大多数散户最后归零，那就是掠夺性的。
Not all dilution is bad and depends on what structure. If you're doing a $600m ATM to build out laser fab capacity with $AAOI for $471m / month H1 2027 (at lower MC ranges), then that's accretive. If you're diluting 15% for NASDAQ listing requirements with $SIVE, and using proceeds for M&A, that's accretive. If you're diluting with $IQE and doing private placements with $MTSI to wipe off old toxic debt, that's accretive. If you're diluting $6,000,000,000 with $IREN, and likely selling that into the open market on every rally off the backs of $SLNH / $BKKT shills where majority of those retail went to 0, then that's predatory.